Search Results - "Soutric, J."

Intravenous Amoxicillin-Sulbactam against Escherichia Coli: Optimizing the Dose, Component Ratio and Infusion Time Using a Human Pharmacodynamic Model by Bantar, C., Fernandez Canigia, L., Berger, M.A., Soutric, J.L., Arenoso, H.J.

“…Amoxicillin-sulbactam (AMX-SUL) is an aminopenicillin/β-lactamase inhibitor combination currently available in 29 countries which may be a suitable option for…”
Get full text

Review of pharmacokinetic, pharmacodynamic and clinical studies with a modern combination of amoxicillin/sulbactam by Soutric, J, Bantar, C, Caruso, N, Heguilén, R, Casellas, Jr, J M, Casellas, J M, Farinati, A, Jasovich, A, Arenoso, H, Rodriguez, M

“…Amoxicillin/sulbactam is a modern antimicrobial combination. This combination proved to be useful for the treatment of several infections caused by different…”
Get more information

An Ex-Vivo Pharmacodynamic Study Comparing Bactericidal Activity of Amoxicillin/Sulbactam, Azithromycin, Doxycycline and Levofloxacin Against Streptococcus pneumoniae by Bantar, C., Nicola, F., Arenoso, H., Soutric, J., Caruso, N., Fernández Canigia, L.

“…We designed a 4-way crossover, Ex-Vivo pharmacodynamic study to compare the bactericidal rate of amoxicillin/sulbactam (AMX-SUL), azithromycin (AZM),…”
Get full text

A Pharmacodynamic Model to Support a 12-Hour Dosing Interval for Amoxicillin/Sulbactam, a Novel Oral Combination, in the Treatment of Community-Acquired Lower Respiratory Tract Infections by Bantar, C., Nicola, F., Canigia, L. Fernandez, Arenoso, H.J., Soutric, J., Montoto, M., Blanco, M., Smayevsky, J., Jasovich, A.

“…We evaluated, by time-kill studies, the pharmacodynamics of amoxicillin/sul-bactam (AMX/SUL, 875 mg/125 mg), a novel oral combination, against the major…”
Get full text

Rationale for Treating Community-Acquired Lower Respiratory Tract Infections with Amoxicillin/Sulbactam Combination Through Pharmacodynamic Analysis in the Setting of Aminopenicillin-Resistant Organisms by Bantar, C., Nicola, F., Canigia, L. Fernandez, Arenoso, H.J., Soutric, J., Montoto, M., Blanco, M., Smayevsky, J., Jasovich, A.

“…In order to establish a rationale for treating community-acquired lower respiratory tract infections, we assess here the pharmacodynamics of…”
Get full text

Efficacy of Amoxicillin-Sulbactam, Given Twice-a-Day, for the Treatment of Community-Acquired Pneumonia: A Clinical Trial Based on a Pharmacodynamic Model by Jasovich, A., Soutric, J., Morera, G., Mastruzzo, M., Vesco, E., Izaguirre, M., Mobilia, L., Prieto, S., Franco, D., Curcio, D., Absi, R., Larrateguy, L., Bustos, J.L., Oliva, M.E., Arenoso, H., Bantar, C.

“…The present multicenter study reports the results of a clinical trial, designed on the basis of a pharmacodynamic study published previously (Bantar et al., J…”
Get full text

Review of clinical studies of alprazolam 0.5 mg tablets designed for sublingual administration by Marquez, M, Arenoso, H, Soutric, J, Caruso, N

Get full text

Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children by Casellas, Javier María, Israele, Víctor, Marín, Marcelo, Ishida, María T., Heguilen, Ricardo, Soutric, Jorge, Arenoso, Héctor, Sibbald, Andrés, Stamboulian, Daniel

“…Streptococcus pneumoniae (Sp) and Haemophilus influenzae (Hi) are the leading bacterial cause of acute otitis media (AOM), having the nasopharynx (NP) as their…”
Get full text

Acid-supressing capacity of omeprazole 20 mg tablets vs pantoprazole 20 and 40 mg tablets. A pilot study in volunteers by Corti, R, Améndola, R, Menéndez, Graciela, Diwecj, Judith, Schenone, Liliana, Soutric, J, Caruso, N

“…To compare the acid-supressing capacity of omeprazole (OZ) 20 mg tablets vs pantoprazole (PZ) 20 and 40 mg tablets, in healthy volunteers, with 24-h…”
Get more information

Bacteriology in infected abortion by Farinati, A., Soler, C.O., Pagniez, G., Gliosca, L., Casellas, J., Guntin, R., Gambaro, E., Soutric, J., Arenoso, H., Caruso, N.

Get full text

Escherichia coli eradication from the blader urine by amoxicillin-sulbactam. Intrinsic activity of the inhibitor by Casellas, J M, Visser, M, Tomé, G, Cohen, H, Soutric, J, Arenoso, H

“…At urine concentrations obtained after the oral administration of amoxicillin-sulbactam (500/500 mg) this combination inhibits roughly 90% of Escherichia coli…”
Get full text

Urine inhibitory titers against resistant Escherichia coli isolates after oral amoxicillin-sulbactam by Casellas, José M, Visser, Matías, MacDougall, Natalia, Tomé, Gabriela, Cohen, Hugo Sabban, Soutric, Jorge, Arenoso, Héctor

“…It has been previously shown that following the oral administration of amoxicillin-sulbactam (AXS) the urinary activity against Escherichia coli (Ec) is due to…”
Get full text

Ambulatory ergometric and pressurometric results with a daily dose of 240 mg of diltiazem in labile hypertensive patients with threshold ergometry by Yasky, J, Godoy, J, Soutric, J L, Arenoso, H J

“…The pharmacological treatment of hypertension raises not only the dilemma of the election of the most suitable drugs given to each patient, but also that of an…”
Get more information

The pharmacokinetic study of a daily dose of theophylline by Arenoso, H J, Dall, L L, Soutric, J L, Martin, J

“…Theophylline pharmacokinetics, administered in tablets containing 600 mg in a sustained-release hydrophilic matrix for a once daily intake, was evaluated after…”
Get more information

Results obtained with pyridinocarbamate in the treatment of atherosclerosis in different parta of the body by Bronstein, J, Galeano, J C, Soutric, J L, Steinman, J, Novaro Hueyo, J A

Get more information